Innate Pharma SA (IPHA) stock
Close on Nov 11, 2026Market cap $149.01MP/E –Yield –
Innate Pharma statistics
62 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- –
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- 14.12
- 4.20
Share statisticsIndustry
- Shares Change (YoY)
- 10.5%
- 5.61%
- Float
- 79M
- 79M
- Shares Held by Insiders
- 16.2%
- 9.05%
- Shares Held by Institutions
- 0.21%
- 20.8%
Short sellingIndustry
- Short Interest
- 123,237
- –
- Short Interest Change
- -2.86%
- -2.55%
- Days to Cover
- 8.92
- 3.54
Stock price statisticsIndustry
- Price Change (1 Week)
- 11.6%
- 2.02%
- Price Change (1 Month)
- 8.16%
- 8.16%
- Price Change (3 Months)
- -37.3%
- -13.7%
- Price Change (6 Months)
- 20.5%
- -4.97%
- Price Change (YTD)
- -9.14%
- -8.54%
- Price Change (1 Year)
- -30.9%
- -15.2%
- Price Change (3 Years)
- -32.9%
- -7.58%
- Price Change (5 Years)
- -68.8%
- -53.0%
- Average Volume (10 Days)
- 19,070
- –
- Average Volume (20 Days)
- 16,580
- –
- Average Volume (90 Days)
- 116,633
- –
- Relative Volume
- 0.06
- 0.70
- Relative Strength Index (14)
- 55.0
- 55.5
- Volatility (1 Year)
- 94.9%
- 65.1%
- Beta (5 Years)
- 0.95
- 0.87
MarginsIndustry
- Pretax Margin
- -546.1%
- -36.6%
- EBITDA Margin
- -584.4%
- -28.6%
- FCF Margin
- -587.4%
- -24.4%
Returns on capitalIndustry
- Return on Capital Employed (ROCE)
- -2888.1%
- -23.8%
Financial positionIndustry
- Current Ratio
- 0.60
- 3.49
- Quick Ratio
- 0.46
- 1.51
- Interest Coverage
- -17.31
- -0.71
GrowthIndustry
- Revenue Growth (YoY)
- -55.2%
- -1.08%
- Revenue Growth (3Y CAGR)
- -46.2%
- 1.61%
- Revenue Growth (5Y CAGR)
- -33.6%
- 14.0%
EfficiencyIndustry
- Asset Turnover
- 0.14
- 0.31
- Revenue Per Employee
- €49.75K
- €855.98K
- Employee Count
- 181
- 304
- WACC
- 9.63%
- 9.37%
Income statement (TTM)Industry
- Pretax Income
- -€49.18M
- -€47.40M
Balance sheetIndustry
- Net Cash (Debt)
- €6.46M
- €111.50M
- Net Cash Per Share
- 0.07 EUR
- 1.53 EUR
- Working Capital
- -€13.26M
- €119.55M
Cash flow (TTM)Industry
- Capital Expenditures
- -€140.00K
- -€2.34M
- FCF Per Share
- -0.56 EUR
- -0.48 EUR
Dividends and yieldsIndustry
- FCF Yield
- -39.6%
- -13.2%
- Buyback Yield
- -11.2%
- -10.6%
- Shareholder Yield
- -11.2%
- -10.6%
Taxes and interestIndustry
- Interest Expense
- €3.12M
- €55.20M
- Income Tax
- €0
- €80.00K
Scores and fair valueIndustry
- Altman Z-Score
- -4.27
- 1.20
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | IPHA | S&P 500 | Difference | IPHA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -1.9% | -2.4% | +0.6 pts | ||
| 3 months | -26.0% | -1.2% | −24.9 pts | ||
| Year to date | -9.1% | +12.3% | −21.4 pts | ||
| 1 year | -25.7% | +12.4% | −38.1 pts | ||
| 3 years | -32.9% | +78.8% | −111.7 pts | -12.5% | +21.4% |
| 5 years | -70.3% | +75.2% | −145.4 pts | -21.5% | +11.9% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M IPHA shares were sold short on Oct 30, 2026, down 2.9% from the previous report. At recent volumes it would take 8.9 days to buy them back. Over the last 20 sessions, 55.2% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 123,237 | -2.9% | 13,823 | 8.9 |
| Oct 15, 2026 | 126,864 | +43.2% | 48,087 | 2.6 |
| Sep 30, 2026 | 88,622 | +16.5% | 71,100 | 1.3 |
| Sep 15, 2026 | 76,073 | -7.2% | 18,580 | 4.1 |
| Aug 31, 2026 | 81,961 | -63.9% | 45,216 | 1.8 |
| Aug 14, 2026 | 227,041 | +48.9% | 721,354 | 1.0 |
| Jul 31, 2026 | 152,432 | -6.8% | 5,534 | 27.5 |
| Jul 15, 2026 | 163,552 | -9.1% | 7,171 | 22.8 |
| Jun 30, 2026 | 179,942 | -14.0% | 12,356 | 14.6 |
| Jun 15, 2026 | 209,331 | +8.0% | 60,643 | 3.5 |
| May 29, 2026 | 193,882 | -21.1% | 38,620 | 5.0 |
| May 15, 2026 | 245,729 | +171.5% | 236,746 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?